A randomized single-blinded placebo-controlled trial was conducted with LLLT ( wavelength , 809 nm ; power , 60 mW ; pulse frequency , 1800 Hz ; duration , 80 seconds per treatment ; dose , 6.3 J/cm ( 2 ) ) in 40 patients with RAS .